Nvidia Is Under DOJ Scrutiny for Its $20 Billion Groq Deal. How Investors Should Play NVDA Stock Now.
Nvidia (NVDA) faces DOJ scrutiny over its $20B licensing deal with AI startup Groq, which some lawmakers allege may avoid antitrust reviews. Nvidia reports Q2 2027 revenue of $96.2B, up 106% YoY, with strong data center growth and positive earnings guidance. Analysts rate NVDA 'Strong Buy' with a mean target price of $326.09, suggesting 49% upside.
How this was made
The 30-second read
Why it matters
The DOJ investigation adds a new risk layer that could affect Nvidia's valuation and the broader AI hardware market.
Market read
Regulatory risk to a market‑dominant AI chipmaker, with potential spillover to the semiconductor sector.
What to watch
The licensing structure may limit DOJ's leverage; ongoing revenue growth and strong AWS orders could offset regulatory risk.
Background
Nvidia recently reported strong Q2 FY2027 results and announced a large AWS GPU deployment, while regulators in multiple jurisdictions have previously examined its acquisitions.
Ticker impact
Nvidia is facing a new DOJ antitrust probe into its $20B Groq licensing deal, a fresh regulatory development not previously reported.
Short-term downside pressure; possible 5‑10% dip if the probe escalates.
Regulatory scrutiny of a major AI acquisition is material; investors typically react negatively to antitrust risk.
Market effects
AI chip sector may see heightened regulatory focus, affecting peers like AMD and Intel.
U.S. markets could see a dip in semiconductor indices; Asian markets may react to potential supply chain disruptions.
The probe underscores global competition concerns, influencing broader tech sentiment.
Counterpoint
If the DOJ ultimately clears the deal, Nvidia could benefit from unimpeded AI expansion, making the stock a long‑term buy.
Key entities
- CompanyNvidia
US‑listed AI chipmaker (NVDA).
- RegulatorDepartment of Justice
U.S. antitrust authority reviewing the Groq licensing deal.
